澳大利亚乳房器械注册中心比较直接植入与两阶段乳房再造
基于澳大利亚乳房器械注册中心(ABDR)2015至2018年5152例假体乳房再造的队列研究显示,直接植入(DTI)组修正手术率为15.6%,高于两阶段组的9.7%(P<0.001);两组患者满意度相似,但DTI组患者体验更好。
要点
- DTI组修正手术率15.6%,两阶段组9.7%(P<0.001)。
- 两组修正最常见原因均为包膜挛缩和假体移位。
- 脱细胞真皮基质使用与更高修正风险显著相关(P=0.028)。
核心结论
- ABDR数据显示DTI再造修正率高于两阶段再造,但患者满意度相当且患者体验更好。
- 包膜挛缩和器械移位是两队列修正的主要原因。
研究设计与样本
- 队列研究,分析澳大利亚乳房器械注册中心(ABDR)2015至2018年乳房切除术后假体乳房再造患者。
- 共记录5152例乳房再造,其中两阶段3093例、DTI 2059例。
- 比较确定性假体植入后的DTI与两阶段队列,记录修正手术率、修正原因和患者报告结局指标。
- 统计方法包括Fisher精确检验或卡方检验、Wilcoxon秩和检验或t检验、Nelson-Aalen累积发病率估计和Cox比例风险回归。
主要发现
- DTI组总体修正手术率为15.6%(中位随访24.7个月),两阶段组为9.7%(中位随访26.5个月;P<0.001)。
- DTI组与两阶段组修正原因中,包膜挛缩为25.2% vs 26.7%(P=0.714),假体移位为26.7% vs 34.3%(P=0.045)。
- 多因素分析发现脱细胞真皮基质使用与更高修正风险显著相关(P=0.028)。
- 放疗对修正率的影响无法研究。
- 两组患者满意度水平相似,但DTI组患者体验优于两阶段组。
局限性
- 放疗对修正率的影响无法研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There remains a lack of clarity surrounding the benefits, risks, and outcomes between two-stage expander/implant reconstruction and single-stage direct-to-implant (DTI) reconstruction. This study used a national data set to examine real-world outcomes of two-stage and DTI reconstructions. METHODS: A cohort study was conducted examining patients in the Australian Breast Device Registry (ABDR) from 2015 to 2018 who underwent prosthetic breast reconstruction following mastectomy. DTI and two-stage cohorts after definitive implant insertion were compared. Rate of revision surgery, reasons for revision, and patient-reported outcome measures were recorded. Statistical analysis was undertaken using Fisher exact or chi-square, Wilcoxon rank sum, or t tests; Nelson-Aalen cumulative incidence estimates; and Cox proportional hazards regression. RESULTS: A total of 5152 breast reconstructions were recorded, including 3093 two-stage and 2059 DTI reconstructions. Overall revision surgery rates were 15.6% for DTI (median follow-up, 24.7 months), compared with 9.7% in the two-stage cohort (median follow-up, 26.5 months; P < 0.001). The most common reasons for revision for DTI and two-stage reconstruction were capsular contracture (25.2% versus 26.7%; P = 0.714) and implant malposition (26.7% versus 34.3%; P = 0.045). Multivariate analysis found acellular dermal matrix use ( P = 0.028) was significantly associated with a higher risk of revision. The influence of radiotherapy on revision rates was unable to be studied. Patient satisfaction levels were similar between reconstructive groups; however, patient experience was better in the DTI cohort than in the two-stage cohort. CONCLUSIONS: The ABDR data set demonstrated that DTI reconstruction had a higher revision rate than two-stage, but with comparable patient satisfaction and better patient experience. Capsular contracture and device malposition were leading causes of revision in both cohorts. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Hoque SS, Zhou J, Gartoulla P, et al. Comparing Direct-to-Implant and Two-Stage Breast Reconstruction in the Australian Breast Device Registry. Plast Reconstr Surg. 2022. PMID: 36729564. doi:10.1097/PRS.0000000000010066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。